EUROPEAN SCREENINGPORT GMBH - Germany 

Ranking results:

Past rankings:

2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000
2011
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2011-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 7
As coordinator: 0
As participant: 7
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2014 0 15.952.730 1.893.297 3
2013 0 9.299.790 822.394 2
2011 0 8.997.787 697.651 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
GENEDATA2
HYPHA DISCOVERY LIMITED2
4SC DISCOVERY1
AALBORG UNIVERSITET1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
ARTTIC1
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN1
BIOCEROS BV1
BIOVERSYS1
CENTRO NACIONAL DE PESQUISA EM ENERGIA E MATERIAS ASSOCIACAO PRIVADA1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL1
CLINICAL GENE NETWORKS AB1
DEUTSCHES HERZZENTRUM MUNCHEN1
FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL1
FUNDACAO OSWALDO CRUZ1
GEMEINNUTZIGE SALZBURGER LANDESKLINIKEN BETRIEBSGESELLSCHAFT1
GERMEDIQ FORSCHUNGSUND ENTWICKLUNGSGESELLSCHAFT MBH1
HELMHOLTZ ZENTRUM FUR OZEANFORSCHUNG KIEL1
HITS GGMBH1
HORIZON DISCOVERY LIMITED1
INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR IBMC1
INTERFACE EUROPE1
IOTA PHARMACEUTICALS1
JACOBS UNIVERSITY BREMEN GGMBH1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
NANION TECHNOLOGIES1
NATIONAL CENTER FOR RESEARCH1
NATIONAL HELLENIC RESEARCH FOUNDATION1
ODENSE UNIVERSITETSHOSPITAL1
OUTSIDE IN1
PROBIODRUG1
ROSLIN CELLAB LIMITED1
STICHTING TOP INSTITUTE PHARMA1
STICHTING VUVUMC1
TEKNOLOGISK INSTITUT FORENING1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS1
THEODOR BILHARZ RESEARCH INSTITUTE1
TYDOCK PHARMA1
UNIVERSIDAD COMPLUTENSE DE MADRID1
UNIVERSIDAD DE ANTOFAGASTA1
UNIVERSITA DEGLI STUDI DI CAGLIARI1
UNIVERSITA DEGLI STUDI DI MODENA E REGGIO EMILIA1
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA1
UNIVERSITA DEGLI STUDI DI SIENA1
UNIVERSITAET BASEL1
UNIVERSITAET ZU LUEBECK1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITAS DIPONEGORO1
UNIVERSITE D'AIX MARSEILLE1
UNIVERSITE DE LILLE II DROIT ET SANTE1
UNIVERSITEIT ANTWERPEN1
UNIVERSITY COLLEGE LONDON1
UNIVERSITY OF AARHUS1
UNIVERSITY OF GLASGOW1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF KENT1
UNIVERSITY OF LEEDS1
UNIVERSITY OF LEICESTER1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF OSLO1
UNIVERSITY OF SURREY1
VTT TECHNICAL RESEARCH CENTRE OF FINLAND1

Constancy:

Total number of partners: 73
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 70
Frequent / Rare Partner Ratio: 0.04

Project overview:

Start dateProjectacronymrolefundingpartners
2014-03-01Parasite-specific cyclic nucleotide phosphodiesterase inhibitors to target Neglected Parasitic Diseases PDE4NPDparticipant6.000.00010
2014-02-01Hanging Drop based automated and parallelized cell technology platform for production and testing DROPTECHparticipant4.051.3194
2014-02-01New Medicines for Trypanosomatidic Infections NMTRYPIparticipant5.901.41114
2013-10-01Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention CVGENES-AT-TARGETparticipant5.995.44912
2013-09-01MOLECULAR BASIS OF ANTIBIOTIC TRANSLOCATION TRANSLOCATIONparticipant3.304.34110
2011-10-01Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population EuRhythDiaparticipant5.997.88917
2011-05-01Natural products from marine fungi for the treatment of cancer MARINE FUNGIparticipant2.999.89813